ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EIGR Eiger BioPharmaceuticals Inc

1.725
0.00 (0.00%)
May 30 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Eiger BioPharmaceuticals Inc EIGR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.725 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.725 1.725
more quote information »

Recent News

Date Time Source Heading
4/01/202410:12GLOBEEiger BioPharmaceuticals Files for Voluntary Chapter 11..
3/11/202415:03EDGAR2Form 8-K - Current report
1/24/202415:59EDGAR2Form 8-K - Current report
1/18/202416:49PRNUSEiger and Partner, AnGes, Receive Approval for ZokinvyĀ®..
1/08/202406:00EDGAR2Form 8-K - Current report
1/04/202407:45EDGAR2Form 8-K - Current report
1/04/202407:00PRNUSEiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse..
12/11/202315:01EDGAR2Form DEF 14A - Other definitive proxy statements
12/04/202305:01EDGAR2Form SC 13D/A - General statement of acquisition of..
12/01/202315:02EDGAR2Form PRE 14A - Other preliminary proxy statements
11/24/202305:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/13/202315:01EDGAR2Form 8-K - Current report
11/09/202315:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:14EDGAR2Form 8-K - Current report
11/09/202315:05PRNUSEiger BioPharmaceuticals Reports Third Quarter 2023..
11/02/202320:54EDGAR2Form SC 13D/A - General statement of acquisition of..
11/02/202320:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202315:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/20/202315:29EDGAR2Form SC 13D - General statement of acquisition of beneficial..
9/28/202315:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
9/12/202316:17DJNEiger BioPharmaceuticals to Discontinue Chronic Hepatitis..
9/12/202315:42EDGAR2Form 8-K - Current report
9/12/202315:05PRNUSEiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon..
9/05/202320:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202320:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/05/202315:05PRNUSEiger BioPharmaceuticals to Present at H.C. Wainwright 25th..
8/15/202305:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
8/14/202315:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202315:09EDGAR2Form 8-K - Current report
8/14/202315:05PRNUSEiger BioPharmaceuticals Reports Second Quarter 2023..
7/28/202315:17EDGAR2Form 8-K - Current report
7/07/202315:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
7/06/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/30/202315:16EDGAR2Form 8-K - Current report
6/29/202307:00PRNUSEiger BioPharmaceuticals to Focus on Metabolic Diseases with..
6/28/202315:05PRNUSEiger BioPharmaceuticals to Host Business Update Call..